Sufentanil Citrate Injection, Solution
Product Images NDC 0409-3382

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sufentanil Citrate (NDC 0409-3382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sufentanil 01)

Chemical structure diagram of sufentanil citrate, showing its molecular components arranged symbolically with atoms and bonds representing the compound's chemical makeup.*

FDA Label Image

Logo (Sufentanil 02)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Label for Sufentanil Citrate Injection, USP, 50 mcg/mL single-dose vial. The label states it is preservative-free, for intravenous and epidural use, and distributed by Hospira, Inc., Lake Forest, IL. The label includes the product NDC 0409-3382-11 and a barcode.*

FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Packaging label for Sufentanil Citrate Injection, USP, 50 mcg/mL in 1 mL single-dose fliptop vials. The carton contains 10 vials, preservative-free, for intravenous and epidural use. The product is distributed by Hospira, Inc. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.